CITICLAV – 625 LB
Powerful Antibiotic with Probiotic Protection
Citric Labs presents CITICLAV-625 LB, a hot-selling broad-spectrum antibiotic formulation designed to fight bacterial infections effectively while supporting gut health. The combination of Amoxycillin, Clavulanic Acid, and Lactic Bacillus helps provide fast infection control with reduced chances of antibiotic-associated stomach discomfort and diarrhea.
Composition
- Amoxycillin 500 mg
- Clavulanic Acid 125 mg
- Lactic Bacillus 60 Million Spores
Key Benefits
- Effective against a wide range of bacterial infections
- Helps prevent bacterial resistance with Clavulanic Acid
- Supports gut flora balance with Lactic Bacillus
- Reduces chances of antibiotic-associated diarrhea
- Fast recovery support for respiratory, urinary, and skin infections
Product Description
CITICLAV-625 LB is a powerful antibiotic tablet by Citric Labs containing Amoxycillin 500 mg, Clavulanic Acid 125 mg, and Lactic Bacillus 60 Million Spores. It is widely used for treating bacterial infections while supporting digestive health and reducing antibiotic-associated discomfort.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
